173 related articles for article (PubMed ID: 31961492)
1. Comparing the Patient-Reported Physical Function Outcome Measures in a Real-Life International Cohort of Patients With Psoriatic Arthritis.
Leung YY; Orbai AM; de Wit M; Balanescu A; Dernis E; Soubrier M; Eder L; Smolen JS; Coates LC; Gossec L;
Arthritis Care Res (Hoboken); 2021 Apr; 73(4):593-602. PubMed ID: 31961492
[TBL] [Abstract][Full Text] [Related]
2. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.
Gossec L; de Wit M; Kiltz U; Braun J; Kalyoncu U; Scrivo R; Maccarone M; Carton L; Otsa K; Sooäär I; Heiberg T; Bertheussen H; Cañete JD; Sánchez Lombarte A; Balanescu A; Dinte A; de Vlam K; Smolen JS; Stamm T; Niedermayer D; Békés G; Veale D; Helliwell P; Parkinson A; Luger T; Kvien TK;
Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice.
Holland R; Tillett W; Korendowych E; Cavill C; Waldron N; Brooke M; McHugh NJ
Ann Rheum Dis; 2018 Mar; 77(3):343-347. PubMed ID: 29146740
[TBL] [Abstract][Full Text] [Related]
4. Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.
Taylor WJ; McPherson KM
Arthritis Rheum; 2007 Jun; 57(5):723-9. PubMed ID: 17530670
[TBL] [Abstract][Full Text] [Related]
5. Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease.
da Cruz Ribeiro E Souza E; da Silva Carneiro SC; Yazbek MA; de Cássia Menin R; Campanholo CB; Carneiro JN; da Silva CHM; Ranza R
Adv Rheumatol; 2020 Sep; 60(1):49. PubMed ID: 32962756
[TBL] [Abstract][Full Text] [Related]
6. Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.
Orbai AM; Perin J; Gorlier C; Coates LC; Kiltz U; Leung YY; Palominos PE; Cañete JD; Scrivo R; Balanescu A; Dernis E; Tälli S; Ruyssen-Witrand A; Soubrier M; Aydin S; Eder L; Gaydukova I; Lubrano E; Kalyoncu U; Richette P; Husni ME; Smolen JS; de Wit M; Gossec L
Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1772-1779. PubMed ID: 31609525
[TBL] [Abstract][Full Text] [Related]
7. Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
Gossec L; Orbai AM; Coates LC; Gladman DD; Ogdie A; Pelligra CG; Ciaravino V; Ink B; Taieb V; Lambert J; de Wit M
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296802
[TBL] [Abstract][Full Text] [Related]
8. A comparison of physical function instruments in psoriatic arthritis: HAQ-DI vs MDHAQ vs PROMIS10 global physical health.
Wan MT; Walsh JA; Craig ET; Husni ME; Scher JU; Reddy SM; Leung YY; Ogdie A
Rheumatology (Oxford); 2021 May; 60(5):2307-2316. PubMed ID: 33313838
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial.
Kavanaugh A; McInnes IB; Krueger GG; Gladman D; Beutler A; Gathany T; Mack M; Tandon N; Han C; Mease P
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1666-73. PubMed ID: 23666608
[TBL] [Abstract][Full Text] [Related]
10. A novel role for the psoriatic arthritis impact of disease (PsAID) questionnaire.
Johnson K; Ye JY; Chandran V; Gladman DD
Semin Arthritis Rheum; 2019 Oct; 49(2):241-245. PubMed ID: 31101369
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic arthritis impact of disease questionnaire: validity, reliability and its clinical potential.
Güler T; Bora Karslı P; Ataman Ş; Bodur H
Rheumatol Int; 2020 Jun; 40(6):959-967. PubMed ID: 32270296
[TBL] [Abstract][Full Text] [Related]
12. Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.
Mease PJ; Asahina A; Gladman DD; Tanaka Y; Tillett W; Ink B; Assudani D; de la Loge C; Coarse J; Eells J; Gossec L
Rheumatology (Oxford); 2023 Feb; 62(2):617-628. PubMed ID: 35789257
[TBL] [Abstract][Full Text] [Related]
13. Functional impairment measurement in psoriatic arthritis: Importance and challenges.
Mease P; Strand V; Gladman D
Semin Arthritis Rheum; 2018 Dec; 48(3):436-448. PubMed ID: 30029795
[TBL] [Abstract][Full Text] [Related]
14. The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting.
Di Carlo M; Becciolini A; Lato V; Crotti C; Favalli EG; Salaffi F
J Rheumatol; 2017 Mar; 44(3):279-285. PubMed ID: 27909086
[TBL] [Abstract][Full Text] [Related]
15. Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study.
Queiro R; Cañete JD; Montoro M; Gómez S; Cábez A;
Arthritis Res Ther; 2020 Apr; 22(1):82. PubMed ID: 32295620
[TBL] [Abstract][Full Text] [Related]
16. Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease.
Walsh JA; Wan MT; Willinger C; Husni ME; Scher JU; Reddy SM; Ogdie A
J Rheumatol; 2020 Oct; 47(10):1496-1505. PubMed ID: 31575704
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Minimal Disease Activity in Psoriatic Arthritis Using the Patient-Reported Outcomes Measurement Information System-Physical Function or the Health Assessment Questionnaire Disability Index.
Chew E; Perin J; Grader-Beck T; Orbai AM
Arthritis Care Res (Hoboken); 2022 Jan; 74(1):151-160. PubMed ID: 32860727
[TBL] [Abstract][Full Text] [Related]
18. Health care utilization and costs associated with functional status in patients with psoriatic arthritis.
Ogdie A; Hwang M; Veeranki P; Portelli A; Sison S; Shafrin J; Pedro S; Hass S; Hur P; Kim N; Yi E; Michaud K
J Manag Care Spec Pharm; 2022 Sep; 28(9):997-1007. PubMed ID: 36001101
[No Abstract] [Full Text] [Related]
19. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
Blackmore MG; Gladman DD; Husted J; Long JA; Farewell VT
J Rheumatol; 1995 May; 22(5):886-93. PubMed ID: 8587077
[TBL] [Abstract][Full Text] [Related]
20. Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry.
Kalyoncu U; Kiraz S; Bilgen SA; Karadag O; Akdogan A; Kilic L; Erden A; Armagan B; Sari A; Ertenli I
Clin Rheumatol; 2019 Apr; 38(4):1187-1192. PubMed ID: 30663017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
